Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES SUN PHARMA ZYDUS LIFESCIENCES/
SUN PHARMA
 
P/E (TTM) x 33.5 41.6 80.6% View Chart
P/BV x 5.7 6.7 84.6% View Chart
Dividend Yield % 0.6 0.7 83.2%  

Financials

 ZYDUS LIFESCIENCES   SUN PHARMA
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-23
SUN PHARMA
Mar-23
ZYDUS LIFESCIENCES/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs4951,072 46.2%   
Low Rs319790 40.4%   
Sales per share (Unadj.) Rs170.3182.9 93.1%  
Earnings per share (Unadj.) Rs19.835.7 55.4%  
Cash flow per share (Unadj.) Rs26.946.2 58.2%  
Dividends per share (Unadj.) Rs6.0011.50 52.2%  
Avg Dividend yield %1.51.2 119.3%  
Book value per share (Unadj.) Rs173.0233.4 74.1%  
Shares outstanding (eoy) m1,012.202,399.34 42.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.45.1 47.0%   
Avg P/E ratio x20.626.1 78.9%  
P/CF ratio (eoy) x15.120.1 75.1%  
Price / Book Value ratio x2.44.0 59.0%  
Dividend payout %30.332.2 94.1%   
Avg Mkt Cap Rs m412,1442,233,361 18.5%   
No. of employees `000NANA-   
Total wages/salary Rs m24,56482,960 29.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m172,374438,857 39.3%  
Other income Rs m4,7468,199 57.9%   
Total revenues Rs m177,120447,055 39.6%   
Gross profit Rs m29,677112,900 26.3%  
Depreciation Rs m7,22725,294 28.6%   
Interest Rs m1,2991,720 75.5%   
Profit before tax Rs m25,89794,084 27.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,8788,476 69.3%   
Profit after tax Rs m20,01985,608 23.4%  
Gross profit margin %17.225.7 66.9%  
Effective tax rate %22.79.0 251.9%   
Net profit margin %11.619.5 59.5%  
BALANCE SHEET DATA
Current assets Rs m100,082398,619 25.1%   
Current liabilities Rs m55,267199,064 27.8%   
Net working cap to sales %26.045.5 57.2%  
Current ratio x1.82.0 90.4%  
Inventory Days Days50147 34.2%  
Debtors Days Days9495 98.3%  
Net fixed assets Rs m144,776376,960 38.4%   
Share capital Rs m1,0122,399 42.2%   
"Free" reserves Rs m174,146557,555 31.2%   
Net worth Rs m175,158559,954 31.3%   
Long term debt Rs m00-   
Total assets Rs m244,940775,794 31.6%  
Interest coverage x20.955.7 37.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.6 124.4%   
Return on assets %8.711.3 77.3%  
Return on equity %11.415.3 74.8%  
Return on capital %15.517.1 90.7%  
Exports to sales %39.20-   
Imports to sales %11.90-   
Exports (fob) Rs m67,577NA-   
Imports (cif) Rs m20,544NA-   
Fx inflow Rs m67,577154,053 43.9%   
Fx outflow Rs m20,54471,511 28.7%   
Net fx Rs m47,03382,541 57.0%   
CASH FLOW
From Operations Rs m26,88849,593 54.2%  
From Investments Rs m11,712-79,437 -14.7%  
From Financial Activity Rs m-44,00423,761 -185.2%  
Net Cashflow Rs m-5,3381,155 -462.2%  

Share Holding

Indian Promoters % 75.0 54.5 137.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.0 36.6 49.3%  
FIIs % 5.0 17.1 29.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 45.5 55.0%  
Shareholders   306,495 612,626 50.0%  
Pledged promoter(s) holding % 0.0 2.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    SUPRIYA LIFESCIENCE     SANOFI INDIA    


More on Cadila Healthcare vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs Sun Pharma Share Price Performance

Period Cadila Healthcare Sun Pharma S&P BSE HEALTHCARE
1-Day -1.17% -0.66% -1.12%
1-Month 7.84% 2.05% -5.16%
1-Year 105.73% 62.41% 57.23%
3-Year CAGR 32.02% 39.22% 18.08%
5-Year CAGR 23.75% 27.17% 18.84%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 30.3%.

Sun Pharma paid Rs 11.5, and its dividend payout ratio stood at 32.2%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.